Home Featured

Featured

Random

PT455 – Psychedelics and Success: Conscious Leadership and Investing in Yourself

PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation

HAVN Life Provides Corporate Update

Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between Their Psychedelic and Non-Psychedelic Effects

Amanita muscaria – A Fresh Look at An Iconic Mushroom

Does Humanity’s Fate Lie in the Hands of the Fungal Kingdom?

PsychedeliCare Launches First European Citizens’ Initiative Demanding Political Action on Psychedelic-Assisted...

Psychedelic Outlaws: Cluster Headaches, Citizen Science, and the Story of ClusterBusters

PsyBio Therapeutics Corp. Begins Trading on the TSX Venture Exchange

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking...

Horizons: Grounds for Collective Effervescence

Interview With Dr. Hyder A. Khoja

Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

Entheon Biomedical Corp. Provides Corporate Update

12 3...292 Page 1 of 292

Psychedelic Funding Update: Q2 2025

Daniel Pinchbeck – From Cultural Catalyst to Capitalist Co-option: Reflections on...

From Senate to Psychedelics: Kyrsten Sinema’s Ibogaine Advocacy Playbook

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.